Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Alaofi, Ahmed Mostafa, . . . Usama A. Fahmy. (2021). Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies. MDPI AG.
Chicago Style (17th ed.) CitationMohammed W. Al-Rabia, et al. Repurposing of Sitagliptin- Melittin Optimized Nanoformula Against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies. MDPI AG, 2021.
MLA (9th ed.) CitationMohammed W. Al-Rabia, et al. Repurposing of Sitagliptin- Melittin Optimized Nanoformula Against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.